Buscopan

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1951-2018
051019512017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
BACKGROUND Hyoscine N-butyl bromide (HBB) acts by inhibiting cholinergic transmission in the abdomino-pelvic parasympathetic… (More)
  • table 1
  • table 2
Is this relevant?
2005
2005
OBJECTIVE To evaluate the efficacy and safety of hyoscine-N-butyl bromide (Buscopan) suppositories in the active phase of labour… (More)
Is this relevant?
2005
2005
PURPOSE To assess primarily the feasibility of magnetic resonance imaging (MRI) as a tool to monitor small bowel peristaltic… (More)
Is this relevant?
2003
2003
The aim of this study was to examine the efficacy of IV Buscopan as a muscle relaxant in CT colonography in terms of colonic… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2003
2003
AIM To evaluate the efficacy of peppermint oil in barium as a spasmolytic agent during a double-contrast barium enema (DCBE… (More)
Is this relevant?
2001
2001
We investigated the effect of Buscopan 20 mg, given at the end of surgery, on analgesic requirements in 44 ASA I and II patients… (More)
Is this relevant?
1995
1995
PURPOSE To compare the spasmolytic effect of glucagon and buscopan in double contrast barium enema examination. PATIENTS AND… (More)
Is this relevant?
1990
1990
A double-blind, randomized parallel group trial comparison involving 712 patients with irritable bowel syndrome was performed… (More)
Is this relevant?
1990
1990
This prospective study was undertaken to establish whether Buscopan (hyosine butyl bromide) interferes with the detection of a… (More)
Is this relevant?
1982
1982
The number of intravenous injections of hyoscine-N-butylbromide (Buscopan) or glucagon required to maintain relaxation of the… (More)
Is this relevant?